ASO Author Reflections: Biopsy Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial

por van Hemert, Annemiek K. E., van Duijnhoven, Frederieke H., Vrancken-Peeters, Marie-Jeanne T. F. D.
Publicado 2023

This house believes that: MARI/TAD is better than sentinel node biopsy after PST for cN+ patients

por van Hemert, Annemiek K.E., van Duijnhoven, Frederieke H., Vrancken Peeters, Marie-Jeanne T.F.D.
Publicado 2023

Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial

por van Hemert, Annemiek K. E., van Duijnhoven, Frederieke H., van Loevezijn, Ariane A., Loo, Claudette E., Wiersma, Terry, Groen, Emilie J., Peeters, Marie-Jeanne T. F. D. Vrancken
Publicado 2023